Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

Author:

Ragelle Héloïse12,Danhier Fabienne3ORCID,Préat Véronique3,Langer Robert14567,Anderson Daniel G.14567

Affiliation:

1. David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA

2. Department of Anesthesiology, Boston Children’s Hospital, Boston, MA, USA

3. Advanced Drug Delivery and Biomaterial, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium

4. Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

5. Harvard-MIT Division of Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA, USA

6. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA

7. Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA, USA

Funder

Leona M. and Harry B. Helmsley Charitable Trust

Fonds National de la Recherche Scientifique FNRS

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Cited by 261 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects;Frontiers in Drug Delivery;2024-01-08

2. Current status and prospects for improved targeted delivery approaches for cancer;Pathology - Research and Practice;2024-01

3. Recent Advancements in the Application of Nanomaterial in Modern Drug Delivery and Future Perspective;Biogenic Nanomaterials for Environmental Sustainability: Principles, Practices, and Opportunities;2024

4. Clinical trials and regulatory aspects of drug delivery system for colonic disorders;Advanced Drug Delivery Systems for Colonic Disorders;2024

5. Biopolymers in Drug and Gene Delivery Systems 2.0;International Journal of Molecular Sciences;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3